扶阳助胃汤剂治疗脾胃虚寒型幽门螺杆菌感染慢性胃炎的临床效果  

Clinical effect of Fuyang Zhuwei Decoction in the treatment of Helicobacter pylori infection chronic gastritis of spleen and stomach deficiency type

作　　者：谢新坤 XIE Xin-kun(Department of Spleen and Stomach Disease,Zhaoqing Hospital of Traditional Chinese Medicine,Guangdong Province,Zhaoqing 526020,China)

机构地区：[1]广东省肇庆市中医院脾胃病科

出　　处：《中国当代医药》2019年第23期149-151,161,共4页China Modern Medicine

基　　金：广东省中医药局科研项目(20162158)

摘　　要：目的探讨扶阳助胃汤剂治疗脾胃虚寒型幽门螺杆菌感染慢性胃炎的临床效果。方法选取2017年1~12月我院收治的60例脾胃虚寒型幽门螺杆菌感染慢性胃炎患者作为研究对象,采用随机分组法将其分为对照组和观察组,每组各30例。对照组患者采用常规西药治疗,观察组患者在对照组的基础上采用扶阳助胃汤剂治疗。观察两组患者的治疗总有效率、幽门螺杆菌感染复发率及治疗前后的中医证候积分及视觉模拟量表(VAS)评分。结果观察组患者的治疗总有效率为83.33%,明显高于对照组的60.00%,差异有统计学意义(P<0.05)。两组患者治疗前的中医证候积分比较,差异无统计学意义(P>0.05);两组患者治疗后的中医证候积分均低于治疗前,差异有统计学意义(P<0.05);观察组患者治疗后的中医证候积分为(13.2±0.9)分,明显低于对照组的(19.7±1.7)分,差异有统计学意义(P<0.05)。观察组患者的复发率为6.67%,明显低于对照组的16.67%,差异有统计学意义(P<0.05)。两组患者治疗前的VAS评分比较,差异无统计学意义(P>0.05);两组患者治疗后的VAS评分均低于治疗前,差异有统计学意义(P<0.05);观察组患者治疗后的VAS评分为(3.1±0.9)分,明显低于对照组(5.9±1.1)分,差异有统计学意义(P<0.05)。结论扶阳助胃汤剂治疗脾胃虚寒型幽门螺杆菌感染慢性胃炎的临床效果显著,能够有效改善患者的病情,降低患者的中医证候积分及复发率,临床值得推广和应用。Objective To explore the clinical effect of Fuyang Zhuwei Decoction in the treatment of Helicobacter pylori infection chronic gastritis of spleen and stomach deficiency type.Methods Sixty patients with chronic gastritis infected with Helicobacter pylori infection of spleen and stomach deficiency type from January to December in 2017 were selected as the study subjects.They were divided into control group and observation group according to the random grouping method,30 cases in each group.The patients in the control group were treated with conventional Western medicine,and the patients in the observation group were treated with Fuyang Zhuwei Decoction on the basis of the control group.The total effective rate of treatment,the recurrence rate of Helicobacter pylori infection,and traditional Chinese medicine(TCM)syndrome score and visual analogue scale(VAS)score before and after treatment were observed in the two groups.Results The total effective rate of treatment in the observation group was 83.33%,which was significantly higher than that in the control group(60.00%),and the difference was statistically significant(P<0.05).There was no significant difference in TCM syndrome score between the two groups before treatment(P>0.05).The scores of TCM syndrome after treatment in both groups were lower than those before treatment,and the differences were statistically significant(P<0.05).The score of TCM syndrome in the observation group was(13.2±0.9)points,which was significantly lower than that in the control group for(19.7±1.7)points,and the difference was statistically significant(P<0.05).The recurrence rate of the observation group was 6.67%,which was significantly lower than that of the control group(16.67%),and the difference was statistically significant(P<0.05).There was no significant difference in VAS score between the two groups before treatment(P>0.05).The scores of VAS after treatment in both groups were lower than those before treatment,and the differences were statistically significant(P<0.05).The score

关 键 词：扶阳助胃汤剂 脾胃虚寒型幽门螺杆菌感染慢性胃炎 临床效果 

分 类 号：R573.3[医药卫生—消化系统]